![Atypical Polycystic Kidney Disease in Individuals Heterozygous for ALG8 Protein-truncating variants | medRxiv Atypical Polycystic Kidney Disease in Individuals Heterozygous for ALG8 Protein-truncating variants | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/07/18/2022.07.13.22277451/F2/graphic-4.large.jpg)
Atypical Polycystic Kidney Disease in Individuals Heterozygous for ALG8 Protein-truncating variants | medRxiv
![Atypical Polycystic Kidney Disease in Individuals Heterozygous for ALG8 Protein-truncating variants | medRxiv Atypical Polycystic Kidney Disease in Individuals Heterozygous for ALG8 Protein-truncating variants | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/07/18/2022.07.13.22277451/F3.large.jpg)
Atypical Polycystic Kidney Disease in Individuals Heterozygous for ALG8 Protein-truncating variants | medRxiv
![ALG8 Rabbit anti-Human, Polyclonal, Novus Biologicals 100 μg; Unconjugated:Antibodies, | Fisher Scientific ALG8 Rabbit anti-Human, Polyclonal, Novus Biologicals 100 μg; Unconjugated:Antibodies, | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/CCG/Novus-Biologicals/antibodies/ALG8%20Antibody-Western%20Blot-NBP2-86798-img0001.jpg-250.jpg)
ALG8 Rabbit anti-Human, Polyclonal, Novus Biologicals 100 μg; Unconjugated:Antibodies, | Fisher Scientific
![Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency) | Journal of Medical Genetics Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency) | Journal of Medical Genetics](https://jmg.bmj.com/content/jmedgenet/41/7/550/F5.large.jpg)
Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency) | Journal of Medical Genetics
![Wide clinical spectrum in ALG8-CDG: clues from molecular findings suggest an explanation for a milder phenotype in the first-described patient | Pediatric Research Wide clinical spectrum in ALG8-CDG: clues from molecular findings suggest an explanation for a milder phenotype in the first-described patient | Pediatric Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41390-018-0231-5/MediaObjects/41390_2018_231_Fig2_HTML.png)
Wide clinical spectrum in ALG8-CDG: clues from molecular findings suggest an explanation for a milder phenotype in the first-described patient | Pediatric Research
![Wide clinical spectrum in ALG8-CDG: clues from molecular findings suggest an explanation for a milder phenotype in the first-described patient | Pediatric Research Wide clinical spectrum in ALG8-CDG: clues from molecular findings suggest an explanation for a milder phenotype in the first-described patient | Pediatric Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41390-018-0231-5/MediaObjects/41390_2018_231_Fig1_HTML.png)
Wide clinical spectrum in ALG8-CDG: clues from molecular findings suggest an explanation for a milder phenotype in the first-described patient | Pediatric Research
![ALG8 Fuels Stemness Through Glycosylation of the WNT/Beta-Catenin Signaling Pathway in Colon Cancer | DNA and Cell Biology ALG8 Fuels Stemness Through Glycosylation of the WNT/Beta-Catenin Signaling Pathway in Colon Cancer | DNA and Cell Biology](https://www.liebertpub.com/cms/10.1089/dna.2022.0165/asset/images/medium/dna.2022.0165_figure2.jpg)